Peter Elkin | Skin Aging Biomarkers | Distinguished Scientist Award

Posted on by Skincare

Dr. Peter Elkin | Skin Aging Biomarkers | Distinguished Scientist Award

Department of Biomedical Informatics | University at Buffalo | United States

Dr. Peter Elkin is a distinguished scientist specializing in biomedical informatics, with expertise in applied ontology, natural language processing (NLP), human factors engineering, and electronic health records (EHRs). His research focuses on leveraging computational methods to extract clinical insights from complex healthcare data, advancing translational research and improving patient outcomes. He has also explored emerging intersections between informatics and biomarker discovery, including applications relevant to skin aging and precision medicine. Dr. Elkin serves as a UB Distinguished Professor and Chair of Biomedical Informatics at the University at Buffalo, where he leads interdisciplinary research and innovation initiatives. His key contributions include pioneering NLP-based systems for detecting clinical complications, advancing clinical terminology standards such as SNOMED CT, and influencing informatics policy frameworks. With impactful innovations and widely cited research, his work bridges data science and healthcare delivery. His vision is to enhance global healthcare systems through intelligent data integration, improving diagnostics, decision-making, and patient-centered innovation.

Citation Metrics (Google Scholar)

10000

500

100

0

Citations
8509

i-index
144

h-index
49

🟦 Citations
🟥 Documents
🟩 h-index

View Google Scholar View Scopus Profile View Orcid Profile

Featured Publications

Kai-An Chuang | Plant-Based Skincare Ingredients | Innovative Research Award

Posted on by Skincare

Dr. Kai-An Chuang | Plant-Based Skincare Ingredients | Innovative Research Award

Technical Assistant Manager | Pegavision corp. | Taiwan

Dr. Kai-An Chuang is a biomedical researcher specializing in pharmacodynamics, toxicology, and advanced bioactive product development, with strong translational expertise bridging laboratory science and industry innovation. His research focuses on neuroprotection, immunomodulation, natural bioactive compounds, extracellular vesicles, and plant-derived therapeutics, with emerging interests in cosmetic and biomedical applications of exosome-like nanoparticles. He currently serves as Technical Assistant Manager at PEGAVISION Corporation and Facial Beau International Corp., where he leads advanced product R&D, and previously worked as a Researcher at the Industrial Technology Research Institute (ITRI) in Taiwan. Dr. Chuang has made significant contributions through mechanistic discoveries in neuroinflammation, immune regulation, and natural compound–based interventions, supporting both therapeutic and commercial translation. His impact vision centers on transforming bioactive natural resources into clinically and industrially relevant solutions, advancing human health, sustainable biotechnology, and global innovation through evidence-based research and cross-sector collaboration.

View ORCID

Featured Publications

 

Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Posted on by Skincare

Prof. Panagiotis Halvatsiotis | Skin Health | Research Excellence Award 

Researcher | University of Athens | Greece

Panagiotis Halvatsiotis is an Assistant Professor of Medicine with specialization in endocrinology and metabolic research, focusing on diabetes, obesity, insulin resistance, and metabolic regulation across clinical and molecular contexts. His research explores skeletal muscle metabolism, protein synthesis, adipokine signaling, and the metabolic impact of nutritional and pharmacological interventions, alongside emerging interests in population-based metabolic risk and COVID-19–related metabolic outcomes. He holds key academic and clinical research roles within university medical settings and has collaborated extensively in multidisciplinary, international research teams. Dr. Halvatsiotis has made significant contributions through high-impact studies elucidating insulin action, amino acid kinetics, and metabolic dysregulation in type 2 diabetes, as well as influential systematic reviews informing dietary and public health policy. His work has generated widely cited evidence shaping clinical practice guidelines. His impact vision centers on translating metabolic research into scalable interventions that improve chronic disease management, inform evidence-based nutrition strategies, and advance global metabolic health innovation.

Citation Metrics (Google Scholar)

1500

1000

600

0

Citations
1455

Documents
17

h-index
28

🟦 Citations
🟥 Documents
🟩 h-index


View Google Scholar

Featured Publications

Marcelo Boriollo | Skincare Ingredients | Research Excellence Award

Posted on by Skincare

Prof. Marcelo Boriollo | Skincare Ingredients | Research Excellence Award

Researcher | Universidade Federal de São Carlos | Brazil

Prof. Marcelo Fabiano Gomes Boriollo is a senior researcher specializing in Medical and Oral Microbiology, with strong expertise in molecular epidemiology, microbial genetics, biofilms, and antimicrobial pharmacology. His research focus centers on the pathogenicity, genotyping, and virulence mechanisms of microorganisms such as Candida spp., Staphylococcus spp., and Enterobacteria, alongside emerging studies on natural products, phytotherapy, and nanoparticle-based antimicrobial strategies. He has held key academic and research positions at leading Brazilian institutions, including Universidade Federal de São Carlos, Universidade Estadual de Campinas, and Universidade José do Rosário Vellano, contributing extensively to research leadership and postgraduate mentoring. Prof. Boriollo’s major contributions include high-impact discoveries in microbial genotyping, biofilm control, antifungal and antibacterial innovations, and the application of natural compounds and nanomaterials against resistant pathogens. His impact vision emphasizes translating microbiological research into clinically relevant solutions, strengthening infection control, advancing public health, and fostering innovation at the interface of microbiology, dentistry, and biomedical sciences.

Citation Metrics (Scopus)

1000

500

200

100

0

Citations
545

Documents
44

h-index
15

🟦 Citations
🟥 Documents
🟩 h-index


View ORCID Profile View Scopus Profile

Featured Publications